News

Eli Lilly's obesity pill remains a viable rival to Novo's oral Wegovy despite data that underwhelmed investors

Eli Lilly's orforglipron could have a few advantages over a pill from Novo Nordisk, including a lack of dietary restrictions ...
BioSpace6h

Weight-Loss Wasteland: 5 Obesity Assets That Failed

The mad rush for safe and effective obesity drugs has winners—including Eli Lilly’s Zepbound and Novo Nordisk’s Wegovy—and ...
Medscape3h

Weight-Loss Pill Matches Injections, but Experts Skeptical

Participants on the 36 mg oral dose drop 12.4% of their body weight at 72 weeks, yet physicians warn of posttreatment weight ...

2 Biotech Stocks That Could Soar 21% and 245% According to Wall Street's Top Analysts

Viking Therapeutics (NASDAQ: VKTX) and Regeneron Pharmaceuticals (NASDAQ: REGN) have faced challenges this year that have ...

I've gone from a size 18 to a size 12 on Mounjaro. Here's EXACTLY how I'm beating the price hike - and how you too can keep losing weight without paying extra

My name is Louise, and I am addicted to Mounjaro. I feel amazing - super healthy, energised, and happier in my skin than I ...

The one, big unanswered question about Ozempic

Eli Lilly will soon bring a pill version to the market, with a version expected to debut at a lower price than injectable Ozempic or Wegovy did. A generic GLP-1 agonist is on track to arrive at ...